GlassScriptPhysician profile
Nicole Dalessandro
NPI 1265746721
$555.78
in general payments reported to CMS, 2019-2025
10 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.88 · 2020: $64.85 · 2021: $15.23 · 2022: $22.12 · 2023: $86.94 · 2024: $174 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $190.52 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $125.43 | 2024-2025 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Bioventus LLC | $64.85 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $40.86 | 2025 | |
| Averitas Pharma INC. | $24.84 | 2023 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.71 | 2023 | Jublia |
| Djo, LLC | $23.88 | 2019 | |
| Orthofix Medical, INC. | $23.34 | 2025 | Physio-Stim |
| Nevro Corp. | $22.12 | 2022 | |
| Baudax Bio INC. | $15.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Dalessandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.